Letermovir Prophylaxis for Cytomegalovirus (CMV) in Patients With Graft-versus-host Disease

Conditions:   Graft-versus-host-disease;   CMV Intervention:   Drug: Letermovir Sponsor:   Rabin Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials